Cleared Special

K200033 - HemosIL von Willebrand Factor Antigen (FDA 510(k) Clearance)

Aug 2020
Decision
225d
Days
Class 2
Risk

K200033 is an FDA 510(k) clearance for the HemosIL von Willebrand Factor Antigen. This device is classified as a Test, Qualitative And Quantitative Factor Deficiency (Class II - Special Controls, product code GGP).

Submitted by Instrumentation Laboratory CO (Bedford, US). The FDA issued a Cleared decision on August 19, 2020, 225 days after receiving the submission on January 7, 2020.

This device falls under the Hematology FDA review panel. Regulated under 21 CFR 864.7290.

Submission Details

510(k) Number K200033 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 07, 2020
Decision Date August 19, 2020
Days to Decision 225 days
Submission Type Special
Review Panel Hematology (HE)
Summary Summary PDF

Device Classification

Product Code GGP — Test, Qualitative And Quantitative Factor Deficiency
Device Class Class II - Special Controls
CFR Regulation 21 CFR 864.7290